Experts that Issued a Call To Reconsider Screening For Breast Cancer

Breast Cancer Patients without Health Insurance often have to rely on Cancer Trials. At Hybrid Medical Analytics Business Intelligence show
Newly Diagnosed Metastatic Breast Cancer Patients getting Taxanes treatment did 8% better than Breast Cancer Patients receiving Anthracyclines for their treatment. 15 percent of Black Females who get cancer to 7 percent of white Females who get cancer are face with having to have clinical trials because their cancer are diagnosed in
the Metastatic Stage.

For this reason Black Female should not follow this week report
from Experts that Issued a Call To Reconsider Screening For Breast Cancer.

This is not something women of color should follow.

Hybrid Medical Analytics Inc Business Intelligence:

15 % of Black African women is diagnosed with breast cancer to
7 % of white women. One of the great drugs that is use if you are in a high risk group for Breast Cancer is called Nolvadex. Black women, as a population, have higher rates for stroke and pulmonary embolism and lower rates of endometrial cancer, all of which may be increased by Nolvadex.

Percentage of breast cancer patients diagnosed with metastatic disease
(cancer that had spread):

White – 7%

Indian – 11%

Pakistani – 17%

Bangladeshi – 13% (not statistically significant because there were so few Bangladeshi women in this sample)

Black Caribbean – 11%

Black African – 15%

Chinese – 10%

Hybrid Medical Analytics Area of Research

* Breast cancer
* Endocrine system cancer
* Gastrointestinal cancer
* Genitourinary cancer
* Gynaecological cancer
* Haematological cancer
* Head and neck cancer
* Neurooncology
* Paediatric oncology
* Thoracic oncology
* Sarcoma
* Skin cancer
* Epidemiology, cancer prevention, and cancer control
* Supportive care
* Imaging
* Health-care systems